Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type.

ABSTRACT:

Purpose

To evaluate the quality of life (QoL) in long-term testicular cancer (TC) survivors.

Methods

QoL was assessed in TC survivors treated between March 1976 and December 2004 (n = 625) using the EORTC-QLQ-C30 questionnaire, including a TC module. The assessment was performed at two time points (2006: response rate: n = 201/625 (32.2%), median follow-up (FU): 12.9 years (range 1.1-30.9); 2017: response rate: n = 95/201 (47.3%), median FU: 26.2 years (range: 13.0-41.2)). TC survivors were grouped according to treatment strategy, tumour entity, clinical stage and prognosis group. Linear and multiple linear regression analyses were performed, with age and time of follow-up as possible confounders.

Results

Radiation therapy (RT) compared to retroperitoneal lymph node d

SUBMITTER: Heinzelbecker J 

PROVIDER: S-EPMC12460406 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature